Enfusion ENFN
Fintech B2B SaaS Vertical SaaS Enterprise Software Financial Services

Enfusion trades at 5.6x EV/NTM revenue on a $1.33B enterprise value. Revenue grew 13.9% year over year to $52.9M in the quarter ending December 2024, an annual run rate of $211.0M. Enfusion reports net dollar retention of 106%, a 69.0% gross margin, and 16.4-month CAC payback.

ARR ($M)
211
Net Dollar Retention
106%
ARR Growth
14.1%
EV / NTM Revenue
5.6x
Payback Period
16.4
EV / Run Rate
6.3x
Price & Key Metrics
Price Performance
Company Details
Share Price: 10.76
Last Filing Date: 2024-12-31
Last Filing: Form
Founding Year: 1997
IPO Year: 2021
Description
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data.
Categories
Fintech B2B SaaS Vertical SaaS Enterprise Software Financial Services
Valuation
Market Cap: 1,388.049
Enterprise Value: 1,333.569
EV / Revenue Run Rate: 6.3x
EV / NTM Revenue: 5.6x
EV / 2026 Revenue Estimates: --
EV / 2027 Revenue Estimates: --
EV / 2028 Revenue Estimates: --
Key Business Metrics
Net Dollar Retention: 106%
Customers: --
ARR: 211
ARR Growth %: 14%
ARR/Customer ($K): --
ARR/Employee ($K): 184
Revenue
Revenue Run Rate: 211
ARR: 211
2026 Revenue Estimates: --
2027 Revenue Estimates: --
2028 Revenue Estimates: --
LTM Revenue: 201
Last Year Run Rate: 185
Growth
Revenue Growth: 14%
ARR Growth: 14%
Growth Persistence: 94%
2026 Revenue Growth Estimates: --
2027 Revenue Growth Estimates: --
2028 Revenue Growth Estimates: --
Financials
Quarterly
Calendar Year
Frequently Asked Questions

How fast is Enfusion growing?

Enfusion grew revenue 13.9% year over year, reaching $52.9M in the quarter ending December 2024.

What multiple does Enfusion trade at?

Enfusion trades at 5.6x EV/NTM revenue and 6.3x EV/run-rate, on an enterprise value of $1.33B.

Is Enfusion profitable?

For Enfusion, operating income was $1.6M last quarter and LTM free cash flow margin is 11.9%.

What is Enfusion's net dollar retention?

Enfusion reports net dollar retention of 106%, measuring revenue expansion within its existing customer base.

How long does it take Enfusion to pay back CAC?

Enfusion recovers customer acquisition cost in about 16.4 months.

What sector is Enfusion in?

Public Comps classifies Enfusion under Fintech, B2B SaaS, Vertical SaaS, Enterprise Software, and Financial Services.

Where does Public Comps get Enfusion's data?

Figures come from Enfusion's own SEC filings, normalised into a consistent quarterly format and refreshed after each earnings release.